title: Amyloid Neuropathy Following Domino Liver Transplantation: Response to Diflunisal.
authors.affiliation: Division of Neurology, Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.
authors.forename: Pierre R
authors.initials: PR
authors.lastname: Bourque
authors.affiliation: Division of Neurology, Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.
authors.forename: Sharmi
authors.initials: S
authors.lastname: Shafi
authors.affiliation: Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.
authors.forename: Gerard H
authors.initials: GH
authors.lastname: Jansen
authors.affiliation: Department of Hematology, The Ottawa Hospital, Ottawa, Ontario, Canada.
authors.forename: Arleigh
authors.initials: A
authors.lastname: McCurdy
authors.affiliation: Division of Neurology, Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada4Ottawa Hospital Research Institute, Ottawa, Ontario, Canada5Department of Genetics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
authors.forename: Jodi
authors.initials: J
authors.lastname: Warman Chardon
mesh_terms: D000368:Aged; D017772:Amyloid Neuropathies / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D004061:Diflunisal / Q000627:therapeutic use*; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects* / Q000639:trends; D008297:Male; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D004061:Diflunisal